0001104659-22-065202.txt : 20220628 0001104659-22-065202.hdr.sgml : 20220628 20220526145052 ACCESSION NUMBER: 0001104659-22-065202 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220526 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Armata Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0000921114 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911549568 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 4503 GLENCOE AVENUE CITY: MARINA DEL REY STATE: CA ZIP: 90292 BUSINESS PHONE: 310-665-2928 MAIL ADDRESS: STREET 1: 4503 GLENCOE AVENUE CITY: MARINA DEL REY STATE: CA ZIP: 90292 FORMER COMPANY: FORMER CONFORMED NAME: AmpliPhi Biosciences Corp DATE OF NAME CHANGE: 20130222 FORMER COMPANY: FORMER CONFORMED NAME: TARGETED GENETICS CORP /WA/ DATE OF NAME CHANGE: 19940331 CORRESP 1 filename1.htm

ARMATA PHARMACEUTICALS, INC.

4503 Glencoe Avenue

Marina del Rey, California 90292-3552

 

May 26, 2022

 

VIA EDGAR SUBMISSION

 

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, DC 20549

 

Re:

Armata Pharmaceuticals, Inc. (the “Company”)

Registration Statement on Form S-3 (File No. 333-264961) (the “Registration Statement”)

 

Dear Ladies and Gentlemen:

 

Pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Securities Act”), the Company hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on Tuesday, May 31, 2022, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.

 

If you have any questions regarding this request, please contact our outside counsel, Faith Charles of Thompson Hine LLP, at (212) 908-3905 or Naveen Pogula of Thompson Hine LLP, at (404) 541-2913.  Please also call either Faith Charles or Naveen Pogula as soon as the Company’s Registration Statement on Form S-3 has been declared effective.  Thank you for your attention to this matter.

 

  Sincerely,
     
  ARMATA PHARMACEUTICALS, INC.
     
     
  By:  /s/ Brian Varnum
  Name: Brian Varnum
  Title:  Chief Executive Officer

 

 

cc:Faith Charles, Thompson Hine LLP

Naveen Pogula, Thompson Hine LLP